Ganaxolone, an approved therapy for CDKL5-deficiency disorder, is an inhibitor of PTP1B

Journal:

Journal of Biological Chemistry

Published:

2026-05-20

DOI:

10.1016/j.jbc.2026.113178

Affiliations:

2

Authors:

5

Go to article

Institutions	Authors	Share
Cold Spring Harbor Laboratory (CSHL), United States of America (USA)	4.500000	0.90
State University of New York at Stony Brook (SUNY Stony Brook), United States of America (USA)	0.500000	0.10

Interested in Neurosciences?